Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Number and proportion of brand and generic anti-infectives re-registered from 2005 to 2013

From: Trade agreements and drug access: assessment of the impact of the 2009 Peruvian new drug policy on anti-infectives registration and availability

Years Brand Generic Total
n % n % N
2005 121 51.3 115 48.7 236
2006 116 50.9 112 49.1 228
2007 116 51.6 109 48.4 225
2008 155 60.3 102 39.7 257
2009 81 44.8 100 55.2 181
2010 114 58.5 81 41.5 195
2011 71 51.4 67 48.6 138
2012 32 47.1 36 52.9 68
2013 6 54.5 5 45.5 11